Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition

Deyu LI; Qin TONG; Yuane LIAN; Zhizhong CHEN; Yaru ZHU; Weimei HUANG; Yang WEN; Qiongyao WANG; Shumei LIANG; Man LI; Jianjing ZHENG; Zhenhua LIU; Huanxin LIU; Linlang GUO.
Cancer Research and Treatment ; : 1042-1056, 2021.
Artículo en Inglés | WPRIM | ID: wpr-913797

Documentos relacionados

  1. Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-ß1 Mediated Epithelial-to-Mesenchymal Transition.
  2. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
  3. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer.
  4. LncRNA TRHDE-AS1 and MiR-1275 as Promising Prognostic Biomarkers and Effects on Tumor Cell Progression in Gastric Cancer.
  5. c-JUN-induced upregulation of LINC00174 contributes to colorectal cancer proliferation and invasion through accelerating USP21 expression.
  6. Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA.
  7. LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer.
  8. Long Non-Coding RNA BCYRN1 Drives Cellular Processes to Promote Asthma Development.
  9. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
  10. LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR/ERK axis.